🇺🇸 FDA

Company profile · Sponsor

Nanjing

Nanjing Zenshine Pharmaceuticals

EDEEF9F · NMPA pharma CN
Pipeline
8
Drugs
0
Patents
0

Quick answer

Nanjing (EDEEF9F) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EDEEF9F
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (8)

Search pipeline →

  1. Camrelizumab Plus Apatinib

    Nanjing

    Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  2. Pre-operative chemotherapy

    Nanjing

    Gastric Cancers

    phase 2 small molecule active

    1 trial

  3. Rezvilutamide

    Nanjing

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  4. low-dose lymphocyte immunotherapy

    Nanjing

    Unexplained Recurrent Miscarriage and Recurrent Implantation Failure

    phase 2 other completed

    1 trial

  5. RJK-RT2831 dose-escalation phase Ia

    Nanjing

    Hematologic Malignancies

    phase 1 small molecule active

    1 trial

  6. TQB2101 for Injection

    Nanjing

    Advanced Hematologic Malignancies

    phase 1 small molecule active

    1 trial

  7. Normal Saline

    Nanjing

    Breast Feeding

    approved small molecule completed

    1 trial

  8. S-ketamine

    Nanjing

    Opioid Use, Unspecified

    small molecule active

    1 trial

Frequently asked questions

What is Nanjing?

Nanjing (EDEEF9F) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Nanjing sponsor?

We track 8 ClinicalTrials.gov-linked programs for Nanjing, including Camrelizumab Plus Apatinib and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Nanjing company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.